Company profile: BAG Health Care
1.1 - Company Overview
Company description
- Provider of contract pharmaceutical manufacturing specializing in sterile filling and freeze-drying of injectables (vials and ampoules) from clinical to commercial scales. Offers analytical quality control, stability studies per ICH guidelines, labelling, and GMP-compliant packaging. Also creates, manufactures, and markets in vitro diagnostic devices and environmental monitoring products.
Products and services
- Analytical service: Conducts incoming goods inspection, in-process controls, and end product testing with cooperation from qualified contract laboratories, enabling comprehensive, contract-lab-integrated quality control across required analytical methods
- Freeze-drying: Produces lyophilized products and supports development, scale-up, and optimization of sterile preparation processes for clinical and commercial production, delivering scale-up-capable manufacturing for injectables
- Sterile filling: Executes sterile filling of pharmaceutical products, including vials and ampoules, with batch sizes from clinical quantities up to 200 liters for commercial purposes, at clinical-to-commercial scale
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BAG Health Care
Eurolyser Diagnostica
HQ: Austria
Website
- Description: Provider of point-of-care testing devices and kits for medical diagnostics, helping doctors determine patient needs more quickly and precisely to commence treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurolyser Diagnostica company profile →
ProciseDx
HQ: United States
Website
- Description: Provider of point-of-care diagnostic solutions for physician offices, retail clinics, and urgent care, delivering rapid, lab-quality results. Offerings include tests for infliximab (Procise IFX), adalimumab (Procise ADL), C-reactive protein (Procise CRP), fecal calprotectin (Procise FCP), and the ProciseDx Instrument for quantitative immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProciseDx company profile →
Alerion Biomedical
HQ: United States
Website
- Description: Provider of biomarker and medical imaging solutions, offering clinical imaging modalities including CT, optical, and MRI.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alerion Biomedical company profile →
CTI Molecular Imaging
HQ: United States
Website
- Description: Provider of imaging solutions for the healthcare industry; CTI Molecular Imaging was acquired and now operates as Siemens Molecular Imaging, a subsidiary of Siemens Medical Solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTI Molecular Imaging company profile →
AES Chemunex
HQ: France
Website
- Description: Provider of conventional and novel culture media, rapid microbiology testing methods, laboratory instruments, and cytometry for microorganism detection, serving applications in the food, pharmaceutical, and cosmetic industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AES Chemunex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BAG Health Care
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BAG Health Care
2.2 - Growth funds investing in similar companies to BAG Health Care
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BAG Health Care
4.2 - Public trading comparable groups for BAG Health Care
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →